Loading...
HomeMy WebLinkAboutNC0006564_Performance Audit Inspection_20170426J�tiSED STq�s �'�, � T Z o � 2 a �1yT1 4 PRO'iseo' UNITED STATES ENVIRONMENTAL PROTECTION AGENCY REGION 4 ATLANTA FEDERAL CENTER 61 FORSYTH STREET ATLANTA, GEORGIA 30303-8960 APR 2 6 2017 CERTIFIED MAIL 7016 1970 0000 8992 6793 RETURN RECEIPT REQUESTED Mr. Jay Zimmerman Director, Division of Water Resources North Carolina Department of Environment and Natural Resources 1601 Mail Service Center Raleigh, North Carolina 27699 Re: Performance Audit Inspection National Pollutant Discharge Elimination System Permit No. NC0006564 Dear Mr. Zimmerman: The purpose of this letter is to transmit the National Pollutant Discharge Elimination System (NPDES) Performance Audit Inspection report for the Baxter Healthcare Corporation wastewater treatment laboratory, which was conducted by staff from Region 4 of the U.S. Environmental Protection Agency's Science and Ecosystem Support Division on February 23, 2017. The overall NPDES program was determined to be satisfactory. A report documenting the performance audit is enclosed for your review. If you should have any further questions regarding the enclosed report, please contact Ms. Mary Mattox at (404) 562-9733 or via email at mattox.mary@epa.gov. Sincerely4Hoeyy, Mau ' e ,Chief Municipal & Industrial Enforcement Section NPDES Permitting and Enforcement Branch Enclosure cc: Mr. Jason Smith North Carolina Department of Environmental _Quality Internet Address (URL) • http://www.epa.gov Recycled/Recyclable • Printed with Vegetable Oil Based Inks on Recycled Paper (Minimum 30% Postconsumer) Project ID: 17-0252 Performance Audit InspectionLU %Q%''OO Baxter Healthcare Corporation 0 NPDES Permit NC0006564 65 Pitts Station Road Marion, North Carolina Project Date: February 23, 2017 Report Date: February 28, 2017 _ Project Leader: Bill Simpson Enforcement Section Field Services Branch 1=1_ Science & Ecosystem Support Division 73- - - - r—�- USEPA — Region 4 980 College Station Road Athens, Georgia 30605-2720 The activities depicted in this report are accredited under the US EPA Region 4 Science and Ecosystem Support Division ISO/IEC 17025 accreditation issued by the ANSI-ASQ National Accreditation Board. Refer to certificate and scope of accreditation AT -1644. SESD Project ID Number: 17-0252 1 of 7 Request®r: Maurice Horsey, Chief Municipal and Industrial Enforcement Section NPDES Permitting and Enforcement Branch USEPA Region 4, 61 Forsyth St. SW Atlanta, Georgia 303-8960 Approvals: SESD Project Leader: Bill Simpson Enforcement Section Field Services Branch 980 College Station Road Athens, GA 30605-2720 Approving Official: Mike Bowden, Chief Enforcement Section Field Services Branch 980 College Station Road Athens, GA 30605-2720 Date Date SESD Project ID Number: 17-0252 2 of 7 1.0 INTRODUCTION On February 23, 2017, the United States Environmental Protection Agency (U.S.EPA) and the North Carolina Department of Environmental Quality (NCDEQ) performed an on-site evaluation of the Baxter Healthcare Corporation wastewater treatment laboratory. The on-site evaluation consisted of discussions with laboratory staff/analysts, an inspection of the facilities and equipment, record reviews, a review of ' operating procedures, and a review of quality assurance activities. Representing the EPA and NCDEQ during the on-site evaluation included: Mr. Bill Simpson, U.S.EPA, Physical Scientist Mr. Jason Smith, NCDEQ, Chemist II The on-site evaluation began with an opening conference that included a round of introductions of the auditors and representative staff from Baxter Healthcare. An explanation of the goals and objectives of the evaluation was made by EPA staff. Later the same day a closing conference was held between the EPA and NCDEQ auditors and representative staff of Baxter Healthcare. The purpose of the post assessment conference was for the auditors to summarize the general findings from the on-site evaluation, discuss the schedule for the findings report and answer questions. This report presents the findings and recommendations from the on-site evaluation. The key managerial staff from Baxter Healthcare participating in the assessment included: Mr. Stephen D. Taylor, WWTP Supervisor, EHS Mr. Michael J. Pisarik, Senior Environmental Engineer, EHS. 2.0 GENERAL LABORATORY DISCUSSIONS AND FINDINGS Observation The wastewater treatment laboratory was staffed with qualified analysts and supervisory personnel. The wastewater treatment laboratory was housed in acceptable facilities with adequate workspace. The laboratory had ample equipment to perform day to day operations. Laboratory instrumentation appeared to be in excellent operating condition. All analytical instrumentation necessary for performing analysis associated with National Pollutant Discharge Elimination System (NPDES) Permit NC0006564 was available for inspection. The laboratory water purification system for providing ASTM Type I water to the laboratory was functioning properly at the time of the laboratory evaluation. It was observed that the Quality Assurance Manual which contained the Standard Operating Procedures (SOPs) were kept in a bound three ring binder. At the time of the audit, the laboratory was conducting all the analysis associated with the permit except oil and grease and chronic toxicity. Pace Analytical Laboratories, Huntersville, NC was analyzing oil and grease as a contract laboratory. SESD Project ID Number: 17-0252 3 of 7 The current permit status is listed in Table 1. TABLE 1 Current Permit Status Parameter Monthly Average Measurement Sample type Sample Frequency Location Influent and Flow 1.2 MGD Continuous Recording , Effluent 460.9 pounds/day 3/Week Composite Influent and BODS Effluent COD 1,292.8 pounds/day 3/Week Composite Influent and Effluent TSS 278,0 pounds/day 3/Week Composite Effluent Fecal Coliforms (MPN) 200/100 mL 3/Week Grab Effluent and UandD Total Residual Chlorine Daily limit of 28 ug/L 3/Week Grab Effluent Oil and Grease 47.7 pounds/day Weekly Grab Effluent Field Parameters: pH, Effluent and temperature, conductivity, and U and D dissolved oxygen pH between 6.0 and 3/Week Grab 9.0 standard units Report only Parameters 2/Month for Composite Effluent NH3-N N113 -N, mg/L No permitted limits All others Total Nitrogen, mg/L monthly Total Phosphorus, mg/L Chronic Toxicity SESD Project ID Number: 17-0252 4 of 7 Findings, for the EPA Region 4's NPDES laboratory assessments, are defined as factual, objective statements which provide evidence of non-conformance with any of the following and which may adversely affect the quality of the data. Findings are supported with the citations to applicable regulations. • The Current NPDES Permit NC0006564, effective date, September 1, 2016. • Official agency mandates and policies i.e. Title 40 of the Code of. Federal Regulations (40 CFR) Part 122.41, conditions applicable to all permits, 40 CFR Part 136.3, identification of test procedures, 40 CFR Part136.7 quality assurance and quality control. • Standard Methods for the examination of water and wastewater. Recommendations are those corrective measures that would enhance laboratory operations, but are not mandatory. The EPA strongly encourages implementation of the recommendations to better conform to standard laboratory practices currently employed within the environmental industry. Corrective Actions are those actions initiated in response to an identified nonconformance, in order to define a problem, attempt to identify the root cause and determine how to prevent the problem from recurring. FINDINGS/CORRECTIVE ACTIONS The following discussions present the findings, corrective actions and recommendations based on the on-site evaluation and review of the documents submitted by the laboratory. 3.0 GENERAL LABORATORY QUALITY AND DOCUMENTATION 3.1 Finding: The standard, operating procedures were incomplete, and in need of revision. Corrective Action: 40 CFR 136.7 states "for example, Standard Methods contains QA/QC procedures in the Part 1000 section of the Standard Methods Compendium." In accordance with part 1020 of Standard Methods," Standard Operating Procedures describe the analytical methods to be used in the laboratory in sufficient detail that a competent analyst unfamiliar with the method can conduct a reliable review and/or obtain acceptable results." 3.2 Finding: The use of dedicated glassware (for QC samples) was observed for the biochemical oxygen demand test. This is considered an unacceptable laboratory practice. Corrective Action: In accordance with'Standard Methods, part 5210B sect. 6c "Dilution water blank serves as a check on quality of unseeded dilution water and cleanliness of incubation bottles." The cleanliness of all bottles cannot be ascertained if only one bottle is utilized for the blank. If the glassware is dedicated; and not rotated, there is no way to demonstrate that the cleaning protocol is acceptable. SESD Project ID Number: 17-0252 5 of 7 3.3 Finding: The method requires an additional Glucose -Glutamic acid check, for a total of three quality control checks, per sample batch of 20, for BODS analysis. Corrective Action: In accordance with Standard Methods, part 5210B sect. 6b "Add sufficient amounts of standard glucose -glutamic acid solution (5210B.3h) to give 3.0 mg glucose/L and 3.0 mg glutamic acid/L in each of three test bottles. The resulting average BOD for the three bottles, after correction for dilution and seeding, must fall into the range of 198 ± 30.5 mg/L." 4.0 CONCLUSIONS In evaluating the Baxter Healthcare wastewater treatment laboratory, the facility is following the analytical methods specified in 40 CFR part 136. The laboratory had appropriate safety equipment and emergency equipment available. The laboratory conducts QC checks on equipment, instrumentation calibration and standard solutions. The laboratory maintains appropriate records of reagent preparation, instrument calibration and maintenance. The laboratory is producing defensible data with a known precision and accuracy. SESD Project ID Number: 17-0252 6 of 7 REFERENCES: The following SESD field measurement and reference procedures were followed during this Performance Audit Inspection, as applicable: SESDPROC-306-R3 Wastewater Sampling SESDPROC-109-R4 Wastewater Flow Sampling SESDPROC-100-R4 Field pH SESDPROC-106-R3 Field Measurement of Dissolved Oxygen SESDPROC-102-R4 Field Temperature SESDPROC-112-R4 Field Measurement of Total Residual Chlorine SESDPROC-101-R6 Field Measurement of Specific Conductance SESDPROC-110-R4 Global Positioning System SESDPROC-111-R3 In-situ water quality monitoring SESD Wastewater Checklist: method SM5210-B Rev 2001, BODS (CBOD) SESD Wastewater Checklist: method SM5220D Chemical Oxygen Demand, Colorimetric SESD Wastewater Checklist: method SM2540D-Determination of Non- Filterable Residue (TSS) SESD Wastewater Checklist: method SM 4500-H+ B, rev 2000 Determination of pH electrometrically SESD Wastewater Checklist: method EPA method 1664B Oil and Grease SESD Wastewater Checklist: Sample Management Procedures SESD Wastewater Checklist: method EPA Method 360.1 Determination of Dissolved Oxygen (DO) SESD Wastewater Checklist: method SM 4500 -CL G, rev 2000 Total Residual Chlorine, DPD Colorimetric Method SESD Wastewater Checklist: method SM9222D Determination of Fecal Coliform Bacteria by Membrane Filter Procedure SESD Wastewater Checklist: method SM 4500 -CL G, rev 2000 Total Residual Chlorine, DPD Colorimetric Method END OF REPORT SESD Project ID Number: 17-0252 7 of 7